Anika Therapeutics Inc (ANIK) support and resistance · rev $62.2M
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
This page maps Anika Therapeutics Inc (ANIK) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
ANIK currently screens at market cap $161.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ANIK 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ANIK quote page for the session range and the stock page for the full model.
Not investment advice.